Multiorgan failure and in-hospital mortality in urgent heart transplantation: the PRESAGIO study

Raquel López-Vilella1, Francisco González-Vílchez2, Daniel Enríquez Vázquez3

  • 1Unidad de Insuficiencia Cardiaca y Trasplante, Hospital Universitari i Politècnic La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.

Insights

In urgent heart transplantation (HT), prolonged mechanical ventilation (MV) and higher Sequential Organ Failure Assessment (SOFA) scores at the time of transplant are linked to increased in-hospital mortality (IHM). These factors are critical for predicting outcomes in high-risk HT candidates.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Critical Care Medicine

Background:

  • Multiorgan failure is a contraindication for heart transplantation (HT).
  • Standardized criteria for multiorgan failure definition exist in Spain.
  • Analyzing these criteria's association with in-hospital mortality (IHM) is crucial for urgent HT candidates.

Purpose of the Study:

  • To assess the association between multiorgan failure criteria at urgent HT listing and at transplantation, and in-hospital mortality (IHM).
  • To evaluate the predictive value of Sequential Organ Failure Assessment (SOFA) scores and mechanical ventilation (MV) duration on IHM in HT recipients.

Main Methods:

  • Ambispective multicenter study of urgent HT procedures (January 2020 - May 2024).
  • Exclusion of patients <17 years, multiorgan transplants, and retransplants (n=328).
  • Analysis of SOFA score, renal replacement therapy, MV, myopathy (MRC scale), and vasoactive-inotropic score (VIS) at listing and transplant.

Main Results:

  • A reduction in SOFA scores was observed during the waiting period (P < .001).
  • Myopathy worsened during the waiting period (3.7% increase in MRC < 36; P = .003).
  • IHM associated with MV duration at inclusion (OR 1.05) and transplant (OR 1.03), and SOFA score 6-11 at transplant (OR 2.13).

Conclusions:

  • Mechanical ventilation (MV) and higher SOFA scores at the time of transplantation are significant predictors of increased IHM in urgent HT.
  • These findings highlight the importance of reassessing organ support status immediately prior to transplantation.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.